Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Cash from Financing Activities (2016 - 2025)

Surgery Partners (SGRY) has disclosed Cash from Financing Activities for 12 consecutive years, with $59.2 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 23.33% to $59.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$57.3 million through Dec 2025, down 121.87% year-over-year, with the annual reading at -$57.3 million for FY2025, 121.87% down from the prior year.
  • Cash from Financing Activities hit $59.2 million in Q4 2025 for Surgery Partners, up from -$84.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $229.8 million in Q4 2021 to a low of -$84.1 million in Q3 2025.
  • Historically, Cash from Financing Activities has averaged $20.4 million across 5 years, with a median of -$30.8 million in 2023.
  • Biggest five-year swings in Cash from Financing Activities: soared 601.75% in 2021 and later crashed 1052.05% in 2025.
  • Year by year, Cash from Financing Activities stood at $229.8 million in 2021, then fell by 15.97% to $193.1 million in 2022, then plummeted by 123.1% to -$44.6 million in 2023, then soared by 207.62% to $48.0 million in 2024, then increased by 23.33% to $59.2 million in 2025.
  • Business Quant data shows Cash from Financing Activities for SGRY at $59.2 million in Q4 2025, -$84.1 million in Q3 2025, and -$62.6 million in Q2 2025.